Bose L1 Pro32 Line Array System

I compared the best XR display glasses right now - the winner was not the most expensive pair

When it comes to Viture, RayNeo, and Xreal, polished spatial tracking beats both raw brightness and future promises.

Broncos’ offensive line fine system ‘all about holding each other accountable’

Getting your Trinity Audio player ready... The Broncos’ offensive line is better for its lighter wallets. Over the past couple seasons, the unit has self-imposed a fine system among its members, with ...

Morningstar

Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer

HONG KONG, Jan. 13, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium ...

Arizona Daily Sun

Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer

The study results showed that the cadonilimab regimen, compared to the PD-1 monoclonal antibody regimen, significantly prolonged patients' overall survival (OS) and progression-free survival (PFS).

The Grand Junction Daily Sentinel

Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer

A recent real-world study provides new evidence addressing this challenge. In this retrospective analysis, patients with PD-L1-low (CPS < 5) advanced G/GEJ cancer received first-line therapy with ...

Eagle-Tribune

First Patient Dosed in SYNERGY-101, a Global, Randomized Phase 2 Clinical Trial of STK-012 in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung Cancer

Synthekine Inc., an engineered cytokine therapeutics company, today announced that the company has dosed the first patient in the SYNERGY-101 study. SYNERGY-101 is a global, randomized Phase 2 ...

New Atlas

Revolutionary full-time 4WD system dumps the diff

Full-time four-wheel drive is one of those annoying things that’s great to have until you really need it. At that point it stops working, unless you undo one of the things that lets it work well the ...

Morningstar

Synthekine Announces Late-Breaking Oral Presentation of Initial Clinical Data of STK-012 Plus Pembrolizumab and Chemotherapy in First-Line, PD-L1 Negative Nonsquamous NSCLC at ...

STK-012 is an α/β biased IL-2 designed to specifically stimulate antigen activated T cells Results from an ongoing Phase 1a/1b to be presented at SITC Company will also present new preclinical data on ...

WBUR

Show inaccessible results

I compared the best XR display glasses right now - the winner was not the most expensive pair

Broncos’ offensive line fine system ‘all about holding each other accountable’

Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer

Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer

Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer

First Patient Dosed in SYNERGY-101, a Global, Randomized Phase 2 Clinical Trial of STK-012 in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung Cancer

Revolutionary full-time 4WD system dumps the diff

Synthekine Announces Late-Breaking Oral Presentation of Initial Clinical Data of STK-012 Plus Pembrolizumab and Chemotherapy in First-Line, PD-L1 Negative Nonsquamous NSCLC at ...

A partial Green Line closure begins Friday — and it's not the only one planned this fall

Green Line D Branch shutdown begins Friday, with more disruptions across system to come in November

This Xiaomi Phone Will Get Powerful 2.1 Sound with Bose Speakers